Transplant Diagnostics Market Outlook
The global transplant diagnostics market is likely to acquire a size of over USD 2,074.65 million during the forecast period, says Market Research Future (MRFR). The report further states that the market is anticipated to register a healthy CAGR of over 7.8% during the assessment era.
The global market for transplant diagnostics has witnessed massive growth in recent years. The transplant diagnostics market growth is being driven by the increasing technological advancements across the healthcare sector. Furthermore, the factors such as the rising number of organic failures, rising prevalence of chronic diseases, expanding funding for R&D institutes, escalating senior population, and the high expenditures related to PCR and NGS devices are also projected to boost the market’s growth over the assessment era.
Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/1324
Transplant Diagnostics Market Segment Analysis
The global transplant diagnostics market has been fragmented into segments based on end-user, product & service, screening type, application, and region.
Based on product & services, the global market for transplant diagnostics is divided into software & services, reagents & consumables, and instruments.
Based on application, the transplant diagnostics market is divided into research applications, diagnostic applications, and others.
By end-user, the global market for transplant diagnostics is divided into hospitals and transplant centers, research laboratories & academic institutes, commercial service providers, and others.
Transplant Diagnostics Market Regional Analysis
The global transplant diagnostics market is examined across five major regions, including Asia-Pacific, Europe, North America, South America, and the Middle East & Africa.
According to the research report by MRFR, the North American region is anticipated to lead the global transplant diagnostics market over the assessment era. The major aspects causing an upsurge in the regional market’s growth are the advancements in the healthcare sector and advanced transplant technologies across the region.
The European region is anticipated to secure the second position in the global market for transplant diagnostics over the projected period. The regional market’s growth is driven by the rising number of organ transplants and donors. Furthermore, the growing government’s support in developing the transplant diagnostics market is projected to boost the demand for transplant diagnostics over the assessment period.
The transplant diagnostics market for the Asia-Pacific region is anticipated to register the highest CAGR over the projection period. The regional market’s growth is attributed to the advanced healthcare infrastructure and a large pool of the patient population. Moreover, developing countries such as China and India are estimated to be the leading markets, another crucial factor in boosting the regional market’s growth over the assessment era. The growing medical tourism destination across the region are projected to profit from the market’s growth over the projected era.
Transplant Diagnostics Market Competitive Analysis
The global transplant diagnostics market has an incredibly competitive landscape. The players in the global market are focusing on the development of advanced technologies to meet the growing demand for minimally invasive procedures worldwide. The players in the global market are adopting various growth policies such as innovations, mergers, etc., strengthening their market position. The list of leading players in the global transplant diagnostics market includes Linkage Biosciences (US.), CareDx (US.), Immucor Transplant Diagnostics Inc. (US.), Bio-Rad Laboratories Inc. (U.S.), Affymetrix Inc. (US.), Thermo Fisher Scientific Inc. (US.), Illumina Inc. (US.), Becton Dickinson and Company (US.), Omixon Ltd. (UK.), Hoffman-La Roche Ltd. (Switzerland), bioMérieux S.A. (France), GenDx (Netherlands), GenDx (Netherlands), QIAGEN NV (Netherlands), Abbott Laboratories Inc. (US.), and many others.
Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/transplant-diagnostics-market-1324
a prominent lung health science leader, SQI Diagnostics Inc., has happily announced a Memorandum of Understanding between Owlstone Medical and SQI to operate together on the innovation, development, and marketing of breath-based biomarkers relating to lung transplant rejection and invasive aspergillus lung infection. The global leader in Breath Biopsy®, Owlstone Medical, is a Cambridge, UK company to save 100,000 lives by fulfilling the immense promise of breath-based diagnostics.
a leader in the science of lung health, SQI Diagnostics Inc., has happily announced the asset acquisition of Precision Biomonitoring Inc.’s TripleLock™ molecular diagnostic testing technology and human diagnostic COVID-19 PCR testing business.
Browse Related Reports at:
Ophthalmic Drugs Market Research Report – Forecast to 2027
DNA Sequencing Market Research Report – Forecast to 2027
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 628 258 0071